IMMX
IMMIX BIOPHARMA (IMMX)
NASDAQ
$8.63+$0.26 (+3.11%)
Price as of Jun 03, 2026 7:41 PM EDT
  • $640.7M
    Market Cap
  • 296.45%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-16.3M
+43.97%
-11.3M
+29.28%
-8.7M
+108.19%
-4.2M
+3,216.11%
Depreciation and Amortization Expense
245,747
+646.02%
32,941
+502.43%
5,468
+156.11%
2,135
-13.49%
Total Operating Expenses
30.0M
+32.11%
22.7M
+40.48%
16.1M
+96.39%
8.2M
+507.90%
Operating Profit
-30.0M
+32.11%
-22.7M
+40.48%
-16.1M
+96.39%
-8.2M
+507.90%
Interest Income
555,526
-45.40%
1.0M
+77.86%
572,006
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-497
-99.72%
Interest Income and Expense and Net
555,526
-45.40%
1.0M
+77.86%
572,006
+115,191.75%
-497
-99.72%
Total Nonoperating Income and Expense
555,526
-45.40%
1.0M
+77.86%
572,006
+115,191.75%
-497
-100.00%
Income before Taxes
-29.4M
+35.75%
-21.7M
+39.10%
-15.6M
+89.42%
-8.2M
-66.28%
Income Taxes
37,724
-8.07%
41,037
+55.35%
26,415
+157.26%
10,268
+70.76%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-29.4M
+36.21%
-21.6M
+40.11%
-15.4M
+87.44%
-8.2M
-66.25%
Net Income from Continuing Operations Applicable to Common
-29.4M
+35.75%
-21.7M
+39.10%
-15.6M
+89.42%
-8.2M
-66.28%
Basic EPS and Net Income
-0.89
+17.11%
-0.76
-14.61%
-0.89
+50.85%
-0.59
-91.11%
Diluted EPS and Net Income
-0.89
+17.11%
-0.76
-14.61%
-0.89
+50.85%
-0.59
-91.11%
Basic Weighted Average Shares
33.0M
+16.55%
28.3M
+63.11%
17.3M
+24.87%
13.9M
+278.13%
Diluted Weighted Average Shares
33.0M
+16.55%
28.3M
+63.11%
17.3M
+24.87%
13.9M
+278.13%
Balance Sheet
Cash and Cash Equivalents
93.9M
+431.21%
17.7M
+0.98%
17.5M
+30.31%
13.4M
-23.85%
Short-Term Investments
6.5M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
100.4M
+467.86%
17.7M
+0.98%
17.5M
+30.31%
13.4M
-23.85%
Total Current Assets
101.2M
+401.23%
20.2M
+2.07%
19.8M
+32.82%
14.9M
-18.08%
Accumulated Depreciation
293,001
+520.04%
47,255
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
2.5M
+44.91%
1.7M
+3,367.74%
50,181
+1,309.58%
3,560
-37.49%
Total Long-Term Assets
20,418
0.00%
20,418
-85.14%
137,410
+1,943.58%
6,724
+18.07%
Total Assets
104.8M
+356.86%
22.9M
+15.17%
19.9M
+33.65%
14.9M
-18.05%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
10.1M
+16.39%
8.7M
+133.41%
3.7M
+192.30%
1.3M
+530.22%
Total Long-Term Debt
2.1M
0.00%
2.1M
0.00%
2.1M
-2.78%
2.2M
+764.00%
Total Long-Term Liabilities
933,625
-7.52%
1.0M
N/A
N/A
N/A
N/A
N/A
Total Liabilities
11.0M
+13.90%
9.7M
+160.54%
3.7M
+112.88%
1.7M
+765.33%
Retained Earnings
-104.5M
+39.24%
-75.0M
+40.47%
-53.4M
+40.61%
-38.0M
+27.66%
Total Stockholders Equity
N/A
N/A
13.3M
-19.23%
16.4M
+24.66%
13.2M
-26.85%
Total Shares Outstanding
53.0M
+92.27%
27.5M
+38.24%
19.9M
+43.41%
13.9M
+5.02%
Cash Flow
Cash from Operating Activities
-23.9M
+63.96%
-14.6M
+28.35%
-11.4M
+53.50%
-7.4M
+366.13%
Capital Expenditures
732,925
-37.77%
1.2M
+2,160.90%
52,089
N/A
N/A
N/A
Cash from Investing Activities
-7.2M
+512.54%
-1.2M
+2,160.90%
-52,089
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
107.4M
+573.33%
15.9M
+3.14%
15.5M
+378.44%
3.2M
-82.85%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-46.07%
-54.30%
-100.82%
+13.84%
-88.57%
+78.12%
-49.73%
N/A
Return on Equity
N/A
N/A
-145.76%
+39.68%
-104.35%
+97.49%
-52.84%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
10.01
+330.67%
2.33
-56.27%
5.32
-54.56%
11.70
N/A
Cash Ratio
9.29
+356.43%
2.04
-56.74%
4.70
-55.42%
10.55
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow